Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of one versus two doses of MVA-BN smallpox vaccine in healthy adults
2005-001781-14Phase 2Completed
- Sponsor
- Bavarian Nordic
- Start
- Feb 2006
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of JYNNEOS in smallpox (4 arms), sponsored by Bavarian Nordic. Primary endpoints: Primary immunogenicity variable, ELISA-specific humoral immune response comparison and 1 more. Started Feb 2006; status: completed.
02
Drugs
JYNNEOS
03
Conditions
smallpox
Beyond the preview
Go deeper on 2005-001781-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2005-001781-14.